Standard Chem & Pharm Co Ltd
TWSE:1720
Standard Chem & Pharm Co Ltd
Current Portion of Long-Term Debt
Standard Chem & Pharm Co Ltd
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Current Portion of Long-Term Debt
NT$82.8m
|
CAGR 3-Years
60%
|
CAGR 5-Years
44%
|
CAGR 10-Years
11%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Current Portion of Long-Term Debt
NT$113.2m
|
CAGR 3-Years
52%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Current Portion of Long-Term Debt
NT$414.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
4%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Current Portion of Long-Term Debt
NT$19.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Current Portion of Long-Term Debt
NT$405.9m
|
CAGR 3-Years
535%
|
CAGR 5-Years
196%
|
CAGR 10-Years
N/A
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Current Portion of Long-Term Debt
NT$3.5B
|
CAGR 3-Years
59%
|
CAGR 5-Years
40%
|
CAGR 10-Years
44%
|
|
Standard Chem & Pharm Co Ltd
Glance View
Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese and western medicine, medicine raw materials, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.
See Also
What is Standard Chem & Pharm Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
82.8m
TWD
Based on the financial report for Dec 31, 2024, Standard Chem & Pharm Co Ltd's Current Portion of Long-Term Debt amounts to 82.8m TWD.
What is Standard Chem & Pharm Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
11%
Over the last year, the Current Portion of Long-Term Debt growth was 0%. The average annual Current Portion of Long-Term Debt growth rates for Standard Chem & Pharm Co Ltd have been 60% over the past three years , 44% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet